Abnova (Taiwan) Corporation operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abnova (Taiwan) with three other
companies in this sector in Taiwan:
sales of 622.44 million Taiwanese Dollars [US$20.21 million]
(290.74 million Taiwanese Dollars [US$9.44 million]
of which 100%
was Medicines), and
Genmont Biotech Inc
(534.72 million Taiwanese Dollars [US$17.36 million]
of which 56%
was Jingyue Company).
During the year ended December of 2015, sales at
Abnova (Taiwan) were 451.37 million Taiwanese Dollars (US$14.66 million).
increase of 3.0%
versus 2014, when the company's sales were 438.11 million Taiwanese Dollars.
Despite this increase, sales are still
below the level achieved in 2013, when Abnova (Taiwan)
reported sales of 463.70 million Taiwanese Dollars.
The sales level in 2015 was fairly close to the level five years ago: in 2010, Abnova (Taiwan) had sales
of 475.07 million Taiwanese Dollars.